Population Screening Using Smartphone in Milpa Alta

Depression Clinical Trial

— Smart-screen  

Official title:

Massive Mental Health Screening Using Smartphone in Milpa Alta Community, Mexico.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04067063
• Other study ID #: SmartMexSurvey1
• Status: Recruiting
• Start date: August 26, 2019
• Est. completion date: April 2021

Study information

• Verified date: July 2020
• Source: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The objective of this study is to make a suicide screening in the entire population of Milpa Alta (approximately 150,000 inhabitants), taking into account other outcomes such as depression, anxiety, alcohol and drugs. For this, an app for Smartphone (MeMind) or a web platform (www.MeMind.net) will be used in which the participants will take a self-administered questionnaire, composed of several psychometric instruments .

It is expected that 70% of the population between 15 and 70 years old can do so directly with their own Smartphone, although web access posts will be enabled in educational and municipal units to avoid discrimination based on age or access to technology.

Our main hypothesis argues that the early identification of people at risk in almost the entire community can be done with an App for Smartphone, serving to depict a map of mental health and related needs of the population, serving for the planning of healthcare services of the local environment, and ultimately for the best assistance of groups and individuals with greater needs through their identification and early reference to medical assistance.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150000
• Est. completion date: April 2021
• Est. primary completion date: January 23, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years to 70 Years

Eligibility

Inclusion Criteria:

1. Use a smartphone as personal or computer terminals enabled by the municipality of Milpa Alta or educational services.

2. Be able to understand the nature, purpose and methodology of the study.

3. Accept participation in the study and check the corresponding box in the app to verify that the informed consent has been expressly given.

Exclusion Criteria:

1. Subject deprived of liberty (by judicial or administrative decision)

2. Subject protected by law (guardianship or conservatorship)

Related Conditions & MeSH terms

• Alcohol Abuse
• Alcoholism
• Anxiety
• Depression
• Depressive Disorder
• Drug Abuse
• Substance-Related Disorders
• Suicidal Ideation

Intervention

Other:
• Self-administered evaluation questionnaire
Smartphone app with MeMind questionnaires

Locations

Country	Name	City	State
Mexico	Alcaldía Milpa Alta. Ciudad de México	Mexico City

Sponsors (6)

Lead Sponsor	Collaborator
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	Centro Interdisciplinario de Ciencias de la Salud, Mexico, Educational Institutions of Milpa Alta, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Milpa Alta Municipalty, Universidad Nacional Autonoma de Mexico

Country where clinical trial is conducted

Mexico, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Suicidal ideation	Columbia-Suicide Severity Rating Scale (C-SSRS) is encompassed into MeMind for this purpose.; In C-SSRS, four constructs are measured. The first is the severity of ideation, which is rated on a 5-point ordinal scale from 1="wish to be dead" to 5="suicidal intent with plan".; The second is the intensity of ideation, which comprises 5 items, each rated on a 5-point ordinal scale: frequency, duration, controllability, deterrents, and reason for ideation.; The third is the behavior, which is rated on a nominal scale that includes actual, aborted, and interrupted attempts; preparatory behavior; and nonsuicidal self-injurious behavior.; And the fourth is the lethality, which assesses actual attempts; actual lethality is rated on a 6-point ordinal scale.; Results are coded in the instrument itself with colored labels that indicates definitions of suicidal ideation and behavior, quantify both of them and gauge their severity.; Definitions are available elsewhere (http://cssrs.columbia.edu).	1 Day
Secondary	Depression	Participants will be asked to complete a questionnaire regarding possible symptoms related to depression.; PHQ-9 questionnaire is emcompassed into Memind for this purpose.	1 Day
Secondary	Anxiety	Participants will be asked to complete a questionnaire regarding possible symptoms related to anxiety.; GAD-7 (only screening questions) is emcompassed into Memind for this purpose.	1 Day
Secondary	Drug Utilization	Participants will be asked to complete a questionnaire regarding possible symptoms related to anxiety.; DAST (only questions 1,6,7) is emcompassed into Memind for this purpose.	1 Day
Secondary	Alcohol Drinking	Participants will be asked to complete a questionnaire regarding possible symptoms related to alcohol abuse.; Alcohol Use Disorders Identification Test (AUDIT-C)	1 Day

External Links

•   Related Info